News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,833 Results
Type
Article (39587)
Company Profile (247)
Press Release (656999)
Multimedia
Podcasts (46)
Webinars (12)
Section
Business (204112)
Career Advice (2007)
Deals (35412)
Drug Delivery (94)
Drug Development (81019)
Employer Resources (172)
FDA (16161)
Job Trends (14848)
News (345079)
Policy (32512)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2552)
Accelerated approval (5)
Adcomms (20)
Allergies (81)
Alliances (49383)
ALS (85)
Alzheimer's disease (1364)
Antibody-drug conjugate (ADC) (111)
Approvals (16165)
Artificial intelligence (235)
Autoimmune disease (19)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (175)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (256)
Cancer (2049)
Cardiovascular disease (164)
Career advice (1674)
Career pathing (29)
CAR-T (142)
Cell therapy (399)
Cervical cancer (19)
Clinical research (65796)
Collaboration (778)
Compensation (489)
Complete response letters (19)
COVID-19 (2581)
CRISPR (37)
C-suite (221)
Cystic fibrosis (99)
Data (2030)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (254)
Diagnostics (6345)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (117)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (88)
Earnings (86267)
Editorial (33)
Employer branding (21)
Employer resources (146)
Events (111799)
Executive appointments (668)
FDA (17311)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (704)
Gene editing (99)
Generative AI (19)
Gene therapy (282)
GLP-1 (689)
Government (4396)
Grass and pollen (4)
Guidances (50)
Healthcare (18810)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (105)
Indications (26)
Infectious disease (2718)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (90)
Interviews (311)
IPO (16490)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (35)
Layoffs (458)
Leadership (16)
Legal (7903)
Liver cancer (71)
Lung cancer (298)
Lymphoma (136)
Machine learning (4)
Management (58)
Manufacturing (275)
MASH (62)
Medical device (13332)
Medtech (13337)
Mergers & acquisitions (19417)
Metabolic disorders (647)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (82)
Neuropsychiatric disorders (24)
Neuroscience (1862)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2494)
Now hiring (37)
Obesity (347)
Opinion (202)
Ovarian cancer (73)
Pain (79)
Pancreatic cancer (79)
Parkinson's disease (143)
Partnered (20)
Patents (213)
Patient recruitment (99)
Peanut (46)
People (57159)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20493)
Phase II (28971)
Phase III (21595)
Pipeline (1088)
Policy (121)
Postmarket research (2563)
Preclinical (8666)
Press Release (64)
Prostate cancer (96)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (366)
Real estate (5905)
Recruiting (65)
Regulatory (22177)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (65)
Series A (123)
Series B (79)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2154)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (16)
The Weekly (27)
United States (21663)
Vaccines (661)
Venture capitalists (37)
Weight loss (226)
Women's health (34)
Worklife (15)
Date
Today (53)
Last 7 days (457)
Last 30 days (2434)
Last 365 days (33051)
2025 (8731)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (51)
Alaska (7)
Arizona (227)
Arkansas (13)
Asia (37729)
Australia (6173)
California (5672)
Canada (1911)
China (481)
Colorado (249)
Connecticut (260)
Delaware (132)
Europe (80941)
Florida (846)
Georgia (198)
Idaho (57)
Illinois (505)
India (24)
Indiana (296)
Iowa (9)
Japan (147)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (846)
Massachusetts (4265)
Michigan (213)
Minnesota (376)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (57)
New Hampshire (62)
New Jersey (1624)
New Mexico (28)
New York (1622)
North Carolina (930)
North Dakota (7)
Northern California (2494)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1282)
Puerto Rico (10)
Rhode Island (29)
South America (1095)
South Carolina (18)
South Dakota (1)
Southern California (2154)
Tennessee (96)
Texas (844)
Utah (169)
Virginia (135)
Washington D.C. (59)
Washington State (524)
West Virginia (3)
Wisconsin (50)
696,833 Results for "ionpath inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Ionpath Announces Shift Toward Spatial Proteomics Services Business
Ionpath, a pioneer in high-definition spatial proteomics, announced a rebalancing of the company’s focus toward its Spatial Proteomics Services.
May 24, 2023
·
2 min read
Business
Ionpath Names Goran Pljevaljcic as Chief Commercial Officer
Ionpath, a pioneer in high-definition spatial proteomics, announced today that Goran Pljevaljcic has joined the company as its Chief Commercial Officer.
November 1, 2022
·
2 min read
Biotech Bay
Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovation
Ionpath, Inc., a leader in high-definition spatial proteomics, announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company.
May 11, 2022
·
2 min read
Biotech Bay
Ionpath Showcases Real-Time Spatial Phenotyping Using MIBI Spatial Proteomics Technology at the Annual Meeting of the Society for Immunotherapy of Cancer
Ionpath, a pioneer in high-definition spatial proteomics, today announced that the results of several studies enabled by multiplexed ion beam imaging (MIBI™) technology will be presented in posters at this week’s annual meeting of the Society for Immunotherapy of Cancer (SITC).
November 8, 2022
·
3 min read
Biotech Bay
Cell Publication Highlights Ionpath MIBI Spatial Proteomics Technology in Foundational Study Predicting Breast Cancer Progression
Ionpath, Inc., the leader in high-definition spatial proteomics, today announced that a peer-reviewed research study led by scientists at Stanford University, Washington University, Duke University, and Arizona State University has been published in the journal Cell.
January 20, 2022
·
3 min read
Biotech Bay
Ionpath Expands Biopharmaceutical Partnerships Program to Rapidly Deliver Novel Insights Utilizing the Company’s High-Definition Spatial Proteomics Platform
Ionpath, Inc. today announced a new program for biopharmaceutical research organizations interested in piloting spatial phenotyping analyses of tissue samples leveraging the company’s Multiplexed Ion Beam Imaging (MIBI™) technology.
August 26, 2021
·
3 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Alcon Agrees to Acquire LENSAR, Inc.
March 25, 2025
·
9 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
1 of 69,684
Next
